877-202-0205     support@chemchart.com     @chemchart
        
Sign In    Register
   Reset Filters

Opioids, Cycloalkanes

Categories

Analgesics (6)
Cyclic compounds (6)
Drugs acting on the nervous system (6)
Opioid receptor ligands (6)
Psychoactive drugs (6)
Cyclobutanes (4)
Four-membered rings (4)
Kappa agonists (4)
Pharmaceuticals (3)
Alcohols (2)
Cyclopropanes (2)
Delta-opioid agonists (2)
Dissociative drugs (2)
Ethers (2)
Semisynthetic opioids (2)
Synthetic opioids (2)
Three-membered rings (2)
Alcohol abuse (1)
Alcohol and health (1)
Analgesic (1)
Convulsants (1)
Kappa antagonists (1)
Ketones (1)
Nervous system drug (1)
Neurotoxins (1)
Opioid antagonists (1)
Substance abuse (1)

Suppliers

Sigma Aldrich (1)

naltrexone (16590-41-3, 16676-29-2)  
ReVia  ·  Trexan  ·  Naltrexone Hydrochloride
Naltrexone, sold under the brand names Revia and Vivitrol among others, is a medication primarily used to manage alcohol dependence and opioid dependence. In opioid dependence, it should not be started until people are detoxified. It is taken by mouth or by injection into a muscle.
butorphanol (42408-82-2, 58786-99-5)  
Stadol  ·  Butorphanol Tartrate  ·  Stadol NS
Butorphanol (BC 2627) is a morphinan-type synthetic agonist–antagonist opioid analgesic developed by Bristol-Myers. Brand name Stadol was recently discontinued by the manufacturer. It is now only available in its generic formulations, manufactured by Novex, Mylan, Apotex and Ben Venue Laboratories.
nalbuphine (20594-83-6)  
Nubain  ·  Nalbuphine Hydrochloride  ·  EN-2234A
Nalbuphine is a semi-synthetic opioid agonist-antagonist used commercially as an analgesic under a variety of trade names, including Nubain and Manfine.
CYCLORPHAN (4163-15-9)  
Cyclorphan is an opioid analgesic of the morphinan family that was never marketed. It acts as a μ-opioid receptor (MOR) weak partial agonist or antagonist, κ-opioid receptor (KOR) full agonist, and, to a much lesser extent, δ-opioid receptor (DOR) agonist (75-fold lower affinity relative to the KOR). The drug was first synthesized in 1964 by scientists at Research Corporation.
Xorphanol (77287-89-9)  
Xorphanol (INN) (developmental code name TR-5379 or TR-5379M), also known as xorphanol mesylate (USAN), is an opioid analgesic of the morphinan family that was never marketed. Xorphanol is a mixed agonist–antagonist of opioid receptors, acting preferentially as a high-efficacy partial agonist/near-full agonist of the κ-opioid receptor (Ki = 0.4 nM; EC50 = 3.3 nM; Imax = 49%; IA = 0.84) and to a lesser extent as a partial agonist of the μ-opioid receptor (Ki = 0.25 nM; IC50 = 3.4 nM; Imax = 29%) with lower relative intrinsic activity and marked antagonistic potential (including the ability to antagonize morphine-induced effects and induce opioid withdrawal in opioid-dependent individuals). The drug has also been found to act as an agonist of the δ-opioid receptor (Ki = 1.0 nM; IC50 = 8 nM; Imax = 76%).
Cogazocine (57653-29-9)  
Cogazocine (INN) is an opioid analgesic of the benzomorphan family which was never marketed.
Related searches
Opioids
Cycloalkanes